The GLP-1 Revolution: Beyond Weight Loss & Glycemic Control

Explore the rapidly evolving world of GLP-1 receptor agonists and next-generation incretin therapies. Sessions can examine cardio metabolic benefits, safety, muscle preservation, weight regain and long-term outcomes. Special focus on combination incretin therapies and where obesity medicine is heading next. Current endocrine congress programming is already placing strong emphasis on the biology, safety and value of GLP-1 therapies.

    Related Conference of The GLP-1 Revolution: Beyond Weight Loss & Glycemic Control

    October 20-21, 2026

    32nd World Diabetes & Heart Congress

    Amsterdam, Netherlands
    October 22-23, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    February 18-19, 2027

    7th International conference on Healthcare Summit

    Singapore City, Singapore
    February 25-26, 2027

    20th International Summit on Diabetes

    London, UK
    March 23-24, 2027

    7th Annual Summit on Diabetes and Endocrinology

    Paris, France
    March 29-30, 2027

    8th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    June 29-30, 2027

    23rd World Congress on Endocrinology & Diabetes

    Paris, France
    July 08-09, 2027

    35th European Diabetes Congress

    Toronto, Canada
    July 15-16, 2027

    7th International conference on Diabetic complications

    Barcelona, Spain

    The GLP-1 Revolution: Beyond Weight Loss & Glycemic Control Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in